Home Laboratory medicine in the European Union
Article Publicly Available

Laboratory medicine in the European Union

  • Wytze P. Oosterhuis

    Wytze Oosterhuis studied chemistry and medicine in Amsterdam and graduated in laboratory medicine in 1991. In 1994 he completed his thesis on applications of multivariate analysis and was registered as medical epidemiologist. Since 1997 he has been active for the IFCC, first in the Committee on Evidence Based Laboratory Medicine, now as lecturer in the IFCC-Abbott Visiting Lecturer Programme. Within the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) he is the chair of the Working Group on guidelines, a joint activity of both EFLM and European Union of Medical Specialists (UEMS). He is the delegate for the Dutch laboratory physicians in the UEMS Section of Laboratory Medicine – Medical Biopathology and chair of the Clinical Chemistry Division. He works as a laboratory physician in The Atrium Medical Center, in Heerlen, The Netherlands.

    EMAIL logo
    and Simone Zerah

    Simone Zerah studied pharmacy and graduated in Paris and at the ‘Jones Institute’ in Norfolk, USA. She specialized in Clinical Chemistry, Hematology, Bacteriology, Immunology, Andrology and Medically assisted conception. She is registered as European Specialist in Laboratory Medicine. She is a former teacher at University Paris V, France. She has a position in several organizations: member of Professional Committee (ex chair) in the EFLM, representative at European and International level of the Societé Française de Biologie Clinique (SFBC), board member of the Syndicat des Laboratoires de Biologie Clinique (SLBC), delegate of SFBC and SLBC at AFNOR (French standardization body), expert at ISO and CEN (International and European standardization bodies), member of the board of «Bioqualité» (French Laboratories qualification) and vice-president of CEPLIS (Comité Européen des professions libérales). She works as co-director of a private medical Laboratory in Bagnolet, near Paris. She is Knight of the French Legion of Honour.

Published/Copyright: July 16, 2014

Abstract

The profession of laboratory medicine differs between countries within the European Union (EU) in many respects. The objective of professional organizations of the promotion of mutual recognition of specialists within the EU is closely related to the free movement of people. This policy translates to equivalence of standards and harmonization of the training curriculum. The aim of the present study is the description of the organization and practice of laboratory medicine within the countries that constitute the EU. A questionnaire covering many aspects of the profession was sent to delegates of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and Union Européenne de Médecins Spécialistes (UEMS) of the 28 EU countries. Results were sent to the delegates for confirmation. Many differences between countries were identified: predominantly medical or scientific professionals; a broad or limited professional field of interest; inclusion of patient treatment; formal or absent recognition; a regulated or absent formal training program; general or minor application of a quality system based on ISO Norms. The harmonization of the postgraduate training of both clinical chemists and of laboratory physicians has been a goal for many years. Differences in the organization of the laboratory professions still exist in the respective countries which all have a long historical development with their own rationality. It is an important challenge to harmonize our profession, and difficult choices will need to be made. Recent developments with respect to the directive on Recognition of Professional Qualifications call for new initiatives to harmonize laboratory medicine both across national borders, and across the borders of scientific and medical professions.

Introduction

The profession of clinical chemistry and laboratory medicine is practiced in all countries in Europe. This profession however, differs between countries in many respects, such as background training, fields of interest, legal status and professional organization.

There are two European organizations that represent national professional organizations in the field of Clinical Chemistry: European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the Union Européenne de Médecins Spécialistes (UEMS), Section of Laboratory Medicine/Medical Biopathology. Both have an important objective to promote mutual recognition of laboratory specialists within the European Union (EU). This is closely related to the free movement of people, a major goal of European integration. This policy translates to equivalence of standards and harmonization of the training curriculum, both the central tasks of the European professional organizations.

The aim of the present study is the description of the organization and practice of clinical chemistry and laboratory medicine within the countries that constitute the EU. This might serve to achieve a better understanding of the profession in the process of harmonization.

Materials and methods

In 2010 the UEMS and EFCC (now EFLM) decided to jointly start this project to investigate the situation of the profession of clinical chemistry within the EU. A questionnaire was developed with open questions about different aspects of the profession: the naming of the profession, fields of interest, number of specialists, number of laboratories, professional organizations, and differences between scientific and medical trained specialists, organization of training and accreditation of laboratories. An explanation of the aim of each question was included.

The questionnaire was sent to delegates of both EFCC and UEMS of the 28 EU countries that are a full member of the EU (Table 1). Uncertainties and omissions were communicated with the respondents and discussed by e-mail. A standardized abstract of the questionnaire was sent to the delegates for confirmation. Local changes during the time of this study were included in the results.

Table 1

Names of specialties and EFLM/IFCC member societies in the European Union countries.

EU countriesName specialtyName professional society (member EFLM) (4,5)
1. AustriaMedizinische und Chemische LabordiagnostikÖsterreichische Gesellschaft für Laboratoriumsmedizin und Klinische Chemie (ÖGLKMC)
2. BelgiumBiologie Clinique; Klinische BiologieSociété Royale Belge de Chimie Clinique, Belgische Vereniging voor Klinische Chemie (KBVKC, SRBCC)
3. Bulgaria
(Clinical Laboratory)
Bulgarian Society of Clinical Laboratory
4. CroatiaSpecijalist Medicinske Biokemije i Laboratorijske MedicineHrvatsko društvo za medicinsku biokemiju i laboratorijsku medicinu (HDMBLM)
5. Cyprus
(Clinical Chemistry)
Association of Clinical Laboratory Directors, Biomedical and Clinical Laboratory Scientists (ACLDBCLS)
6. Czech RepublicKlinická BiochemieČeská společnost klinické biochemie (ČSKB)
7. DenmarkKlinisk BiokemiDansk Selskap for Klinisk Biokemi (DSKB)
8. EstoniaLaborimeditsiinEesti Laborimeditsiini Ühing (ESLM)
9. FinlandKliininen Kemia SairaalakemistiSuomen Kliinisen Kemian Yhdistys (SKKY)
10. FranceBiologie MédicaleSocieté Francaise de Biologie Clinique (SFBC)
11. GermanyLaboratoriumsmedizinDeutsche Vereinte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin e.V. (DGKL)
12. Greece
Greek Soc.Clin. Chem.Clin. Biochem. (EEKX-KB)
13. HungaryOrvosi Laboratóriumi DiagnosztikaMagyar Laboratóriumi Diagnosztikai Társasag (MLDT)
14. IrelandClinical Biochemistry, Clinical ChemistryAssociation of Clinical Biochemists in Ireland (ACBI)
15. ItalyBiochimica ClinicaSocietà Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBIOC)
16. LatviaLaboratora MedicınaLatvijas Laboratorijas Specialistu biedriba (LSB)
17. LithuaniaLaboratorine MedicineLithuanian Society Laboratory Medicine
18. LuxembourgBiologie Clinique/BiochemieSocieté Luxembourgeoise de Biologie Clinique (SLBC)
19. MaltaPatologija Kimika
20. NetherlandsKlinische ChemieNederlandse Vereniging voor Klinische Chemie en Laboratorium Geneeskunde (NVKC)
21. PolandLaboratoryjna Diagnostyka MedycznaPolskie Towarzystwo Diagnostyki Laboratoryjnej (PTDL)
22. PortugalAnálises Clínicas (PharmD); Patologia Clínica (MD)Sociedade Portuguesa de Química Clínica (SPQC)
23. RomaniaMedicina de LaboratorSocietatea Romana de Medicina de Laborator (SRLM)
24. Slovak RepublicLaboratórna medicína/Klinickej biochémieSlovenská spoločnost’ pre laboratórnu medicínu (SSLM)
25. SloveniaMedicinska BiokemijaSlovensko Združenje za Klinično Kemijo (SZKK)
26. SpainBioquímica Clínica (monovalent), Análisis clínicos (polyvalent)Sociedad Española de Bioquimica Clinica y Patolgía Molecular (SEQC)
27. SwedenKlinisk KemiSvensk Förening för Klinisk kemi (SFKK)
28. UKClinical Biochemistry/Chemical PathologyThe Association for Clinical Biochemistry and Laboratory Medicine (ACB)

Results

Out of the 28 countries, all responded except Malta, Latvia and Luxembourg (Table 1). Malta and Luxembourg do not have a training program in their county.

Definition of the specialty

Many different names are used for the specialty field at a national level (Table 1), which is reflected in the EC directives [1, 2]. The words used in different combinations are: clinical, medical, laboratory, (bio)chemistry and diagnostic. Together these words accurately define the profession of clinical chemistry and laboratory medicine. At the European level, the EFCC (now named EFLM) in 2010 has adopted the name of the profession “specialist in laboratory medicine”, after consultation of and voting by the National Societies [3].

Professional societies

The EFLM member societies are listed in Table 1 [4, 5]. Except for Cyprus and (until recently) Croatia, all these professional societies are mixed, with members of both scientific and medical background. About half of the countries reported a separate professional organization exclusively for members of medical background (Cyprus, Czech Republic, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Portugal, Slovakia, Spain and UK).

Number and background of specialists (Table 2)

The academic training before specialization varies between EU countries. All countries have specialists of both medical and scientific background, with medical laboratory professionals being officially recognized as medical specialists. The Netherlands is an exception, where the training of medical specialists was stopped in 2001. In Croatia the medical specialty of laboratory medicine was recently started upon entering the EU. The proportion of medical doctors varies between countries, with at the low end Croatia (0%) and the Netherlands (8.1%), and at the high end Greece (92%) and Austria, that does not have laboratory specialists with a scientific background. The total number of laboratory specialists in the EU is (with background): 14,800 (physicians), 11,300 (pharmacists), and 10,200 (scientists). Medical specialists in laboratory medicine thus comprise around 40% of more than 30,000 practicing laboratory professionals in the EU.

Table 2

Number of laboratory specialists and academic training.

CountriesInhabitants(million)Laboratory specialists (number)Laboratory specialists per million inhabitantsMedical, %Pharmacists, %Scientists, %
1. Austria8.230236.878.5021.5a
2. Belgium10.492585.654.444.50.0
3. Bulgaria7.940551.374.11.224.7
4. Croatia4.324957.900100
5. Cyprus0.8015919918.2081.8
6. Czech Republic10.269067.637.74.358.0
7. Denmark5.514225.853.58.538.0a
8. Estonia1.2917213349.4050.6a
9. Finland5.227853.531.7068.3
10. France61.411,00017927.073.00.0
11. Germany82.3210225.567.7032.4
12. Greece11.0380034692.107.9
13. Hungary9.943143.552.512.535.0
14. Ireland4.2194.252.6088.9
15. Italy57.1590010333.91.764.4
16. Latvia2.2
17. Lithuania3.625078.120.0080.0
18. Luxembourg0.49
19. Malta0.40
20. Netherlands16.524516.58.11.890.1
21. Poland38.2126533.19.19.583.0
22. Portugal10.7174316342.957.10.0
23. Romania22.2232010534.50.964.7
24. Slovak Republic5.551092.738.8061.2
25. Slovenia2.07236.02.848.648.6
26. Spain46.7245053.328.661.210.2
27. Sweden9.124326.754.7045.3a
28. UK60.670011.628.6071.4

aThere is no formal specialization for scientists in laboratory medicine. They can work in a laboratory according to their particular special competence but they do not become specialists.

In five countries pharmacists constitute a high proportion of the laboratory professionals: France (73%), Spain (61%), Portugal (57%), Slovenia (50%) and Belgium (45%). Except for Slovenia, these countries have a training that is almost exclusively restricted to medical doctors and pharmacists. In France both groups have an equal legal position. All other counties, however, have few pharmacists in clinical chemistry. The mean proportion of pharmacists in these 19 countries is 2.1% (range 0%–9.5%). Their training and position is in most cases equal to scientists but not to medical doctors.

The total number of laboratory specialists differs considerably between the EU countries. Expressed as the number of laboratory specialists per inhabitant, Greece has the highest number with 346 per million, followed by Cyprus with almost 200 per million. At the low end are Ireland and the UK with 4.2 and 11.6 per million, respectively. The countries are different with regard to the number of fields of interest that are part of the laboratory medicine specialty. If we take into account six specialized fields [biochemistry, hematology, endocrinology, immunology, transfusion medicine (serology) and microbiology], there is only a weak correlation between the number of laboratory specialists, and the number of specialized fields of the profession.

Academically trained laboratory professionals (Master’s degree) without specialist training do exist in some countries. In the UK these are named “biomedical scientist”. In Croatia, more than half of the people who have studied clinical chemistry find work in the laboratory without further post-academic specialization (280 vs. 249 specialists).

By exception, in some countries technologists have university level training. In Sweden technicians working in the laboratory have a 3-year university degree to become a “licensed practitioner of medicine”. They do not have the level of training to carry out the same responsibilities as a clinical chemist, and are not accepted in the EC4 Register [6].

Fields of interest and responsibilities in clinical chemistry/laboratory medicine (Table 3)

Laboratory medicine does include different fields in different countries. “Laboratoriumsmedizin” in Germany and Austria includes biochemistry, endocrinology, microbiology and hematology and transfusion medicine. This form of general laboratory medicine (however with a special position of transfusion medicine) is practiced in other countries like France and Spain (análisis clinicos). Hematology is only practiced by physicians in Spain, as the specialty includes clinical practice and blood transfusion. However, clinical biochemistry in the UK does not include hematology and microbiology. In most cases, however, the medical laboratory profession in this country (chemical pathology) includes the treatment of outpatients (lipid clinics, metabolic disorders etc.).

Table 3

Laboratory medicine and fields of interest.

BiochemistryEndocrinologyImmunologyHematologyTransfusionMicrobiology
1. AustriaYesYesYesYesYesYes
2. BelgiumYesYesYesYesYesYes
3. BulgariaaYesYesYesYesNoNo
4. CroatiaYesYesYesYesNoNo
5. CyprusbYesYesYesYesPartYes
6. Czech RepublicYesYesPartYesNoNo
7. DenmarkYesYesYesYesNoNo
8. Estoniaa,eYesPartNoYesYesNo
9. FinlandYesYesPartYesYesPart
10. FranceYesYesYesYesYesYes
11.GermanyYesYesYesYesYesbYesb
12. GreecefYesYesYesYesYesYes
13. Hungarya,c, fYesYesYesYesNoYes
14. IrelandYesYesPartNoNoNo
15. ItalyYesYesYesYesNoYes
16. Latvia
17. LithuaniaYesYesYesYesPartYes
18. Luxembourg
19. Malta
20. NetherlandsYesYesYesYesYesNo
21. PolandYesYesYesYesPartNo
22. PortugalYesYesYesYesPartYes
23. RomaniaYesYesYesYesyesYes
24. Slovak RepublicYesYesYesYesPartYes
25. SloveniaYesYesYesYesNoPart
26. SpaindYesYesNoYesNoYes
27. SwedenYesYesPartYesNoNo
28. UKYesYesNoNoNoNo

Part: some laboratories perform these tests, or only in part (e.g., routine tests); only transfusion serology (Slovak Republic); MD, medical doctor; Pharm, Pharmacist; Sc, Scientist. ahematology by MD (Estonia: laboratory hematology); bonly by MD; cHungary: immunology by MD; dIn Spain Bioquímica clínica (monovalent): endocrinology, immunology; Análisis clínicos (polyvalent): hematology, microbiol. (MD); etransfusion by laboratory hematology (MD); fmicrobiology by MD.

Laboratory medicine is sometimes called “polyvalent” or “general” if it includes a broad field of interests, and “monovalent” if it includes only one field of interest (e.g., microbiology, transfusion medicine). We arbitrarily define laboratory medicine here as polyvalent or general, if it includes at least biochemistry, hematology and microbiology. According to that definition, 60% (15/25) of the countries included in this study are polyvalent (Table 3). This corresponds to 83% of all laboratory specialists in the EU working in countries with a polyvalent or general type of laboratory medicine.

Responsibilities of medical and scientific laboratory specialists (Table 4)

There are differences in professional responsibilities between medical and scientific laboratory specialists in European countries. In the Netherlands, clinical chemists with a scientific background can be responsible for all aspects of clinical chemistry, including transfusion medicine. In contrast, clinical chemists in Germany cannot operate but under the responsibility of a laboratory physician or another medical doctor.

Table 4

Position of scientists and pharmacists compared to physicians.

ScientistPharmacist
1. AustriaLimitedNAa
2. BelgiumNAaNot limited
3. BulgariaLimitedlimited
4. CroatiaNot limitedNAa
5. CyprusaNot limitedNAa
6. Czech RepublicNot limitedNot limited
7. DenmarkLimitedLimited
8. EstoniaLimitedLimited
9. FinlandLimitedNAa
10. FranceNAaNot limited
11. GermanyLimitedNAa
12. GreeceLimitedbNAa
13. HungaryLimitedLimited
14. IrelandNot limitedNAa
15. ItalyNot limitedNot limited
16. Latvia
17. LithuaniaNot limitedNAa
18. Luxembourg
19. Malta
20. NetherlandsNot limitedNot limited
21. PolandNot limitedNot limited
22. PortugalLimitedcNot limited
23. RomaniaNot limitedNot limited
24. Slovak RepublicNot limitedNot limited
25. SloveniaNot limitedNot limited
26. SpainNot limitedNot limited
27. SwedenLimitedNAa
28. UKNot limitedNAa

NA, not applicable; aNo specialists, or very limited number; bonly MD can be end responsible in private laboratory; cNot allowed to assume the position of technical director of a laboratory.

The limited responsibilities of laboratory specialists with a scientific background compared to physicians concern the responsibility for diagnosis and patient treatment advice to the clinician, or the end-responsibility of the laboratory work.

In most countries both physicians, pharmacists and laboratory specialists with scientific background can be the head of a laboratory. Sometimes this is restricted to upper grade specialists (UK: consultant level). Most countries, however, do not have different grades.

Pharmacists were reported to have less limitations with respect to responsibilities compared to physicians (not limited 11, limited 4, not applicable 10), than specialists with a scientific background (not limited 14, limited 9, not applicable 2) (Table 4).

Specialist training and registration

The EC4 curriculum [6] was used in 16 countries in the development of the local specialist training curriculum. It was reported to be background information (Finland, Lithuania), or was even identical to EC4 curriculum (France). In the UK there is a close overlap between EC4 and the national curriculum, where the UK curriculum predates that of EC4. In most countries the EC4 curriculum was used for training of scientists or pharmacists, with the exception of six countries (Bulgaria, Estonia, France, Hungary, Lithuania and Slovenia) where it was also used in training of medical specialists.

The UEMS curriculum [7] was used in less countries for the medical training: Finland, Hungary, Portugal and Slovakia. Sweden has a special position, as the UEMS curriculum was adapted based on the Swedish situation.

The duration of the training was calculated as the number of years after completion of the university training. In some countries, there is an obligatory pre-training period, before the training can be started. This period was interpreted to be part of the total specialist training period (Table 5). Some countries have an academical study in clinical chemistry (Croatia and other Balkan countries not included in the EU). Only this study allows trainees to enter the specialist training. In Croatia, about 50% of these academics choose not to do this specialization, and work in clinical laboratories with a limited responsibility.

Table 5

Duration of training, registration and re-registration.

CountriesDuration of trainingExaminationRegistrationRe-registration
MDScPharmMDScPharmMDScPharmMDScPharm
1. Austria6NAaNAbYNNAbYNNAbNNNAb
2. Belgium5NAb5NNAbNYNAbYNgNAbNg
3. Bulgaria43NAbYYNAbYNNAbNNNAb
4. Croatia4h4NAbNAbyNAbYYNAbYYNAb
5. CyprusNAcNAcNAbNAcNAcNAbYYiNAbNNNAb
6. Czech Republic555YYYYYYYYY
7. Denmark6.55a5aNNNYNNNNN
8. Estonia4NAaNAbYNNAbYNNAbNNNAb
9. Finland65NAbYYNAbYYNAbNNNAb
10. France6NAb6Y2YYNAbYYNAbY
11. Germany55NAbYNNAbYYNAbNNNAb
12. Greece55h4hY9NAYYyNYy
13. Hungary545YYYYYyYYy
14. Ireland7d7dNAbYYNAbYYNAbYNNAb
15. Italy555NNNYNNNNn
16. Latvia
17. Lithuania42eNAbYNNAbYNNAbNNNAb
18. LuxembourgNAcNAcNAcNAcNAcNAc
19. MaltaNAcNAcNAcNAcNAcNAc
20. NetherlandsNAc44NAYYYYYNAcYY
21. Poland444YYYYYYNNN
22. Portugal544YYYYYYNYY
23. Romania55a5aYYYYYYYYY
24. Slovak Republic655YYYYYYYYY
25. Slovenia5f5f5fYYYYYYYYY
26. Spain444NNNYYYNNN
27. Sweden5NAaNAbNNNAbYNNAbNNNAb
28. UK5d5NAbYYNAbYYNAbYYNA2

NA, not applicable; MD, medical doctor; Pharm, pharmacist; Sc, scientist. ano formalized training, training “on the job”; bno specialists, or very limited number; cno training available; dduration of training not fixed, 2–3 years pre-registration (before master degree), 5 years post-registration; eadditional training will be introduced; fFour years specialization after 1 year with state examination; gnot obligatory, but stimulated with financial bonus; htraining recently started [8]; ivoluntary.

There is no training of laboratory specialists in Cyprus. It has a system of certificates (after 1 year training) in sub-specialties hematology, biochemistry, immunology and microbiology. Diplomas from abroad are accepted after a validation procedure. Training predominantly takes place in Greece. Malta and Luxembourg do not to have specialist training.

For scientists, there is no formal training in four countries (excluding countries with only physicians and pharmacists): Austria, Estonia, Denmark and Sweden.

Re-registration is obligatory for laboratory physicians in eight countries (9/25, 36%) (Table 5). Re-registration can be linked to a financial stimulus (health insurance reimbursement), while not connected to the losing of registration (Belgium). For specialists with a scientific background, re-registration is obligatory in 11 out of 23 countries (48%). In the 14 countries with a relevant number of pharmacists, nine had a re-registration program (64%).

There was a continuous medical education (CME) program in place in 20 out of 25 countries (80%) (Table 6). In some countries the system is only for physicians (Austria, Germany).

Table 6

Registration, examination and ISO 15189 accreditation.

CountriesOfficial recognitionISO 15189CME system
MDScAccreditation
1. AustriaYN<5%bYg
2. BelgiumYY75%cY
3. BulgariaYY0%N
4. CroatiaYY<5%Y
5. CyprusYY10%N
6. Czech RepublicYY40%Y
7. DenmarkYN30%N
8. EstoniaYN33%Y
9. FinlandYY90%dYh
10. FranceYNAa3.2%Y
11. GermanyYN25%eYg
12. GreeceYN1%Y
13. HungaryYY<5%Y
14. IrelandYY75%Y
15. ItalyYY<5%fY
16. Latvia
17. LithuaniaYY<5%n
18. Luxembourg
19. Malta
20. NetherlandsYN>90%Y
21. PolandYY3–5%Y
22. PortugalYY15%bY
23. RomaniaYY30%Y
24. Slovak RepublicYY20%Y
25. SloveniaYY0%Y
26. SpainYY0.5%Yi
27. SwedenYN100%N
28. UKYY94%Y

NA, not applicable; CME, continuous medical education; MD, medical doctor; Sc, scientist. ano specialists, or very limited number; bfew ISO 15189, majority ISO 9000/9001; cestimated; d90% large laboratories, 15% small laboratories; eprivate 90%, hospital 5%, total number is estimate; flinked to insurance, most ISO 9000/9001; gonly for physicians; hconnected with accreditation according to ISO 15189; iCME used for professional and economical recognition within an institution.

Organization and responsibility of training

The official recognition of the profession of laboratory specialists differs between EU countries. In all countries, the medical laboratory specialty is acknowledged by law, with an official register regulated by the official medical council and/or under responsibility of the ministry of health. For professionals with a scientific background, there was not (or not yet) a register in all countries. There is a register in 16 countries, and no register in seven countries.

From the data it was not always clear, whether the organization holding the register of scientists was private, or officially recognized. In one country (France) it is not applicable, with only physicians and pharmacists admitted to the profession. Pharmacists are recognized in all countries with substantial numbers of specialists with this background training, with the exception of Denmark, where there is only a formal training for physicians.

Accreditation ISO/EN 15189

Quality is a central issue for laboratory profession, and the development of a quality system based on ISO/EN15189 has taken place in many laboratories in the EU. Also in this field there are large differences between countries. Some countries have reached an almost complete introduction of audits and accreditation: Sweden, Finland, The Netherlands, and France, where this is now compulsory by law. Other countries are still at the beginning of this development (Table 6). In some countries ISO 9000 is used – for the time – more predominantly than ISO 15189 (Austria, Italy) and can be obliged by health insurance (Italy).

Although the ISO 15189 is not compulsory by law in Germany, there is a legal regulation called “Richtlinien der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen (RiliBÄK)” which has adopted essential contents of ISO 15189, particularly quality management aspects and management of documents. Therefore, parts of ISO 15189 are also obligatory in Germany.

Discussion

Clinical chemistry and laboratory medicine was defined by the IFCC as the application of chemical, molecular and cellular concepts and techniques to the understanding and the evaluation of human health and disease. At the core of the discipline is the provision of results of measurements and observations, together with interpretation and informed clinical advice relevant to the maintenance of health, the cause of disease, the diagnosis of disease, predicting and monitoring the response to therapy, and follow-up investigations. The discipline is committed to deepening the understanding of health and disease through fundamental and applied research [9].

Notwithstanding the clear definition of the field of interest, many differences exist between countries with respect to a wide variety of aspects of the profession. Harmonization has been an important objective, and has a long history. In 1958 – one year after the treaty of Rome was signed – the representatives delegated by the professional organizations of medical specialists of the six member countries of the very new European Community (EEC), who met in Brussels, created the European Union of Medical Specialists [Union Européenne des Médecins Spécialistes (UEMS)]. The main objectives of the UEMS are: to promote the highest level of training of the medical specialists, medical practice and health care within the EU and to promote free movement of specialist doctors within the EU. The UEMS represents the medical specialist profession in the member states of the EU, to EU authorities and any other authority dealing with questions concerning the medical profession.

In 1988 the FESCC was founded, joining the different national societies for clinical chemistry and laboratory medicine. The harmonization and recognition of laboratory specialists, particularly of scientific and pharmaceutical background, was the main objective from the start. The EC4 was founded, with the goal to harmonize the training and establishing a European register for highly trained specialist, whatever their background.

Between European countries there are many differences: predominantly medical or scientific professionals; an important proportion of pharmacists or a negligible number; a broad professional field of interest including many aspects of laboratory medicine, or a more limited specialized field; inclusion of patient treatment or no clinical tasks; formal recognition and strict regulation by law, or absent recognition and regulation by the profession itself; regulated training with national examination or no formal training program; general or minor application of a quality system based on ISO norms.

The many details of the professional situation in the EU are complicated, and had to be abstracted for practical reasons. The differences between countries are illustrated by some examples. In France, the profession of medical biology (biologie médicale) is regulated by and reserved for medical doctors and pharmacists. The profession covers the fields of microbiology, parasitology and virology, biochemistry, hematology and immunology, IVF and genetics. In Portugal, only medical doctors and pharmacists are allowed to be laboratory directors. In the UK clinical chemistry is a monovalent specialty that covers biochemistry including endocrinology, and is performed by both medical doctors (chemical pathologists) and scientists (clinical biochemists). In Croatia, clinical chemistry includes biochemistry, endocrinology, hematology, immunology and molecular methods but excludes microbiology. At the moment there are only specialists of scientific background in Croatia, but a training program for physicians was started when this country entered the EU. The Netherlands is the only country without training for physicians to become medical laboratory specialists, where the training was stopped in 2001.

It is not so easy to fully document the characteristics in some countries and the differences between the practice of medical and scientific specialists. In Germany the polyvalent laboratory medicine has to be practiced by physicians as this includes microbiology and transfusion medicine with an important diagnostic and advisory task towards clinicians. Laboratory medicine in Slovak Republic is a general (polyvalent) medical discipline with a curriculum matching that of the UEMS, introduced in 2003 when hematology, microbiology and transfusion medicine were included in the curriculum for physicians. Scientists practice the monovalent discipline of clinical biochemistry. The curriculum of both disciplines overlap by 65%. Since the introduction, 10 physicians and 30 scientists have been trained according this new curriculum. In Spain a new law will come into effect this year. The monovalent specialties bioquímica clínica and the polyvalent specialty análisis clínicos will vanish and there will be only one kind of polyvalent specialists in laboratory medicine. This specialty training will accept students with training in medicine, pharmacy, biology and (bio)chemistry.

There are many efforts to harmonize the profession of laboratory medicine within Europe. One aspect of this process is the documentation of the similarities and differences between countries, as was done with our present study. Others in the laboratory profession have undertaken the same task [10, 11]. The EFLM has adopted the name of the specialty to be “specialist in laboratory medicine” [3]. This is expected to make the laboratory profession better recognizable. The EC4 has published an updated version of the guide to the EC4 register which gives the minimum standards of clinical chemistry education and training [6].

The UEMS Section of Laboratory Medicine/clinical biopathology has, however, worked on standards for training that describe the different specialties within the Section (clinical chemistry, hematology, immunology, transfusion medicine, genetics and general/polyvalent laboratory medicine) [7]. Other medical specialties have worked successfully on harmonization within the EU [12]. The laboratory physicians are subject to the same UEMS charters and EC directives as other medical specialists, like the Charter on Training of Medical Specialists [13]; the Charter on Continuing Medical Education [14]; the Charter on Quality Assurance in Medical Practice [15]; the Charter on Visitation of Training Centres [16]. These rules and regulations might pose a special challenge in the harmonization between medical and scientific laboratory specialties.

Recent developments on EU level have opened new opportunities for harmonization. The EC directive on Recognition of Professional Qualifications has been revised and allows harmonization by “Common Training Frameworks” for recognition of professions within the EU when some conditions are met [1, 2]. One of these conditions is the recognition of a candidate profession within one third of the EU countries. European recognition of specialists in laboratory medicine with a scientific or pharmaceutical background might be within reach, starting with a defined profession and harmonized training in at least ten countries. Laboratory specialists of scientific background and of medical background are operating in the same professional domain, however, with other professional opportunities with respect to patient care. The respective training programs show considerable overlap or are in some countries even identical. For that reason this harmonization cannot be regarded as an independent process in the future.

Conclusions

The harmonization of the postgraduate training of both clinical chemists and of laboratory physicians has been a goal for many years, based on the concept of free movement of people within the EU. Much has been achieved within the respective European organizations in the development of curricula. A start has been made towards visitation of laboratories and specialist training across borders. There still exist major differences between the organization of the laboratory profession in the respective countries, which all have a long historical development with their own rationality. It will be an important challenge to harmonize the profession, and difficult choices will need to be made. Recent developments with respect to the EU directive on Recognition of Professional Qualifications call for new initiatives to harmonize laboratory medicine both across national borders, and across the borders of scientific and medical professions.


Corresponding author: Dr. Wytze P. Oosterhuis, Department of Clinical Chemistry and Hematology, Atrium Medical Center, Henri Dunantstraat 5, 6419 PC Heerlen, The Netherlands; and Union Européenne de Medecins Spécialistes (UEMS), Section of Laboratory Medicine, Medical Biopathology, Phone: +31 45 5766341, E-mail:

About the authors

Wytze P. Oosterhuis

Wytze Oosterhuis studied chemistry and medicine in Amsterdam and graduated in laboratory medicine in 1991. In 1994 he completed his thesis on applications of multivariate analysis and was registered as medical epidemiologist. Since 1997 he has been active for the IFCC, first in the Committee on Evidence Based Laboratory Medicine, now as lecturer in the IFCC-Abbott Visiting Lecturer Programme. Within the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) he is the chair of the Working Group on guidelines, a joint activity of both EFLM and European Union of Medical Specialists (UEMS). He is the delegate for the Dutch laboratory physicians in the UEMS Section of Laboratory Medicine – Medical Biopathology and chair of the Clinical Chemistry Division. He works as a laboratory physician in The Atrium Medical Center, in Heerlen, The Netherlands.

Simone Zerah

Simone Zerah studied pharmacy and graduated in Paris and at the ‘Jones Institute’ in Norfolk, USA. She specialized in Clinical Chemistry, Hematology, Bacteriology, Immunology, Andrology and Medically assisted conception. She is registered as European Specialist in Laboratory Medicine. She is a former teacher at University Paris V, France. She has a position in several organizations: member of Professional Committee (ex chair) in the EFLM, representative at European and International level of the Societé Française de Biologie Clinique (SFBC), board member of the Syndicat des Laboratoires de Biologie Clinique (SLBC), delegate of SFBC and SLBC at AFNOR (French standardization body), expert at ISO and CEN (International and European standardization bodies), member of the board of «Bioqualité» (French Laboratories qualification) and vice-president of CEPLIS (Comité Européen des professions libérales). She works as co-director of a private medical Laboratory in Bagnolet, near Paris. She is Knight of the French Legion of Honour.

Acknowledgments

We thank all the participating delegates and other colleagues for participating in this study and supplying us the data. Special thanks to Hein Muyrers for his help with the data management.

Author contributions: Both authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Financial support: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Directive 2013/55/EU of the European Parliament and of the Council of 20 November 2013; amending Directive 2005/36/EC on the recognition of professional qualifications and regulation (EU) No 1024/2012 on administrative cooperation through the internal market information system. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2013:354:0132:0170:en:pdf. Accessed on 13 Apr 2014.Search in Google Scholar

2. Directive 2005/36/EC of the European Parliament and of the Council: recognition of professional qualifications. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2005L0036:20110324:en:pdf. Accessed on 13 Apr 2014.Search in Google Scholar

3. Zérah S, McMurray J, Horváth AR. Our profession now has a European name: specialist in laboratory medicine. EFCC newsletter May 2011. Available from: http://www.efcclm.org/files/efcc/files/EFLM%20Newsletter%202011-05.pdf. Accessed on 13 Apr 2014.Search in Google Scholar

4. Website EFLM. Available from: www.efcclm.org. Accessed on 13 Apr 2014.Search in Google Scholar

5. Website EC4. Available from: http://www.ec-4.org/national_societies.htm. Accessed on 13 Apr 2014.Search in Google Scholar

6. McMurray J, Zerah S, Hallworth M, Schuff-Werner P, Haushofer A, Szekeres T, et al. The European register of specialists in clinical chemistry and laboratory medicine: guide to the register, version 3-2010. Clin Chem Lab Med 2010;48:999–1008.10.1515/CCLM.2010.223Search in Google Scholar PubMed

7. Recommended standards for training specialists in laboratory medicine/medical biopathology. Available from: http://www.uems-slm.org/uems/01-PDF/BB_2012May_Final.pdf. Accessed on 13 Apr 2014.Search in Google Scholar

8. Rizos D, Karababa P, Nikolou C, Sarandakou A, Panagiotakis O, Ferderigou A, et al. The Greek way to the register: the establishment and operation of the register for clinical chemists-clinical biochemists in Greece. Clin Chem Lab Med 2011;49:1975–8.10.1515/CCLM.2011.687Search in Google Scholar PubMed

9. IFCC Handbook. Available from: http://www.ifcc.org/executive-board-and-council/ifcc-handbook-2012-2014/. Accessed on 13 Apr 2014.Search in Google Scholar

10. Questionnaire ESCMID (European society of clinical microbiology and infectious diseases). Available from: http://questionnaire.escmid.org/index.php?id=12. Accessed on 13 Apr 2014.Search in Google Scholar

11. Jansen RT. Self and co-regulation for science and pharmacy specialists in clinical chemistry and laboratory medicine-establishing the system. Available from: http://www.ec-4.org/publications.htm. Accessed on 13 Apr 2014.Search in Google Scholar

12. Duyvené de Wit T, Hellström-Lindberg E, Jäger U, Evans-Jones G, Smand C. H-Net, the European network for harmonization of training in hematology, and its policy. Haematologica 2012;97:1776–8.10.3324/haematol.2012.078964Search in Google Scholar PubMed PubMed Central

13. Charter on training of medical specialists. Available from: http://www.uems.eu/_data/assets/pdf_file/0017/1484/906.pdf.Search in Google Scholar

14. Charter on continuing medical education. Available from: http://www.uems.eu/_data/assets/pdf_file/0020/1478/174.pdf.Search in Google Scholar

15. Charter on quality assurance in medical practice. Available from: http://www.uems.eu/_data/assets/pdf_file/0003/1479/175.pdf.Search in Google Scholar

16. Charter on visitation of training centres. Available from: http://www.uems.eu/_data/assets/pdf_file/0013/1480/179.pdf.Search in Google Scholar

Received: 2014-4-13
Accepted: 2014-6-16
Published Online: 2014-7-16
Published in Print: 2015-1-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Harmonisation of specialist training and continuing professional development in laboratory medicine: a long but necessary journey
  4. Reviews
  5. Laboratory medicine in the European Union
  6. Role of leptin in female reproduction
  7. Mini Review
  8. Interrelatedness between C-reactive protein and oxidized low-density lipoprotein
  9. General Clinical Chemistry and Laboratory Medicine
  10. Comparison of approaches and measurement of continuing professional development for specialists in laboratory medicine within four European countries
  11. Point-of-care urine albumin in general practice offices: effect of participation in an external quality assurance scheme
  12. Triple positive antiphospholipid antibody profile in outpatients with tests for lupus anticoagulants
  13. Effects of cigarette smoking on circulating leukocytes and plasma cytokines in monozygotic twins
  14. Proteolysis is a confounding factor in the interpretation of faecal calprotectin
  15. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients
  16. Cancer Diagnostics
  17. Quantification of adult T-cell leukemia/lymphoma cells using simple four-color flow cytometry
  18. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development
  19. Cardiovascular Diseases
  20. Increased serum homocitrulline concentrations are associated with the severity of coronary artery disease
  21. S100B concentrations increase perioperatively in jugular vein blood despite limited metabolic and inflammatory response to clinically uneventful carotid endarterectomy
  22. Long-term biological variability of galectin-3 after heart transplantation
  23. Diabetes
  24. Evaluation of a next generation direct whole blood enzymatic assay for hemoglobin A1c on the ARCHITECT c8000 chemistry system
  25. The 13C-glucose breath test is a valid non-invasive screening tool to identify metabolic syndrome in adolescents
  26. Comparison of a direct enzymatic assay and polyacrylamide tube gel electrophoresis for measurement of small, dense low-density lipoprotein cholesterol
  27. Letters to the Editor
  28. Comparison of Abbott Architect high-sensitivity troponin I in Rapid Serum Tubes and plasma
  29. Can EDTA, EDTA-fluoride, and buffered citrate tubes be used for measurement of HbA1c on the Bio-Rad D10?
  30. How to reduce EDTA contamination in laboratory specimens: a Tunisian experience
  31. Does mean platelet volume share any relationship with biochemical and hematological parameters?
  32. Association of retrospective markers of glycemia and the use of continuous glucose monitoring in white adults with type 2 diabetes mellitus – a preliminary report
  33. Operative performances and efficiency for infectious disease testing of two immunochemistry analyzers – Abbott ARCHITECT i2000SR and DiaSorin Liaison XL
Downloaded on 3.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0407/html
Scroll to top button